Accelerator Life Science Partners

Accelerator Life Science Partners is a venture capital firm focused on investing in and nurturing early-stage biotechnology companies. The firm is dedicated to advancing life sciences breakthroughs into impactful health solutions. With a strategic approach to biotech investing, Accelerator LSP partners with research institutions and corporate VCs to support emerging biotechnology research opportunities, particularly in New York City and Seattle.

Accelerator Life Science Partners

Portfolio

Rodeo Therapeutics

Acquired by Amgen for $721 million.

#Biotechnology

Lodo Therapeutics

Acquired by Zymergen Inc.

#Biotechnology

ApoGen Biotechnologies

Developing a new class of drugs targeting resistance to cancer therapy.

#Biotechnology

Magnolia Neurosciences

Focused on developing targeted neuroprotective therapies.

#Biotechnology

Proniras

Supporting the development of Tezampanel in the treatment of seizure disorders.

#Biotechnology

Automera

Launched with $16M in Series A commitments in Singapore.

#Biotechnology

KayoThera, Inc.

Nominated a first-in-class, oral inhibitor of the retinoid pathway in genetically defined oncology indications as a development candidate. Raised $8 million in Series A financing led by Accelerator Life Science Partners to develop novel cancer immunotherapeutics.

#Biotechnology

Show Less